Wei Xi

586 total citations
38 papers, 473 citations indexed

About

Wei Xi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Wei Xi has authored 38 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Wei Xi's work include Renal cell carcinoma treatment (23 papers), Renal and related cancers (14 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Wei Xi is often cited by papers focused on Renal cell carcinoma treatment (23 papers), Renal and related cancers (14 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Wei Xi collaborates with scholars based in China. Wei Xi's co-authors include Jianming Guo, Jiejie Xu, Li Liu, Qi Bai, Yu Xia, Qilai Long, Yang Qu, Ying Xiong, Jiajun Wang and Xiaoyi Hu and has published in prestigious journals such as Scientific Reports, The Journal of Urology and Ecotoxicology and Environmental Safety.

In The Last Decade

Wei Xi

36 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xi China 14 244 163 138 120 104 38 473
Lei Yan China 15 342 1.4× 137 0.8× 94 0.7× 162 1.4× 65 0.6× 43 584
Mingwei Chen China 15 404 1.7× 228 1.4× 219 1.6× 122 1.0× 72 0.7× 41 658
Chao‐Tao Tang China 12 190 0.8× 130 0.8× 107 0.8× 88 0.7× 80 0.8× 30 410
Kakil Ibrahim Rasul Qatar 9 183 0.8× 116 0.7× 192 1.4× 122 1.0× 59 0.6× 48 495
Duygu Derin Türkiye 12 178 0.7× 79 0.5× 181 1.3× 81 0.7× 60 0.6× 24 424
Andrew R. Zaretsky Russia 10 237 1.0× 76 0.5× 118 0.9× 169 1.4× 53 0.5× 28 431
Tzu-Chin Wu Taiwan 17 395 1.6× 92 0.6× 196 1.4× 186 1.6× 75 0.7× 18 616
Bojian Xie China 11 212 0.9× 105 0.6× 110 0.8× 187 1.6× 59 0.6× 26 454
Yihua Huang China 12 161 0.7× 231 1.4× 284 2.1× 94 0.8× 58 0.6× 44 494

Countries citing papers authored by Wei Xi

Since Specialization
Citations

This map shows the geographic impact of Wei Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xi more than expected).

Fields of papers citing papers by Wei Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xi. The network helps show where Wei Xi may publish in the future.

Co-authorship network of co-authors of Wei Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xi. A scholar is included among the top collaborators of Wei Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xi. Wei Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Xue, et al.. (2023). Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours. Japanese Journal of Clinical Oncology. 54(3). 339–345. 1 indexed citations
3.
Tang, Jie, Wei Xi, Hang Wang, et al.. (2023). Clinical Significance of Preoperative Assessment of Intravesical Prostatic Protrusion in Radical Prostatectomy. Journal of Cancer. 14(15). 2889–2894.
4.
Xi, Wei, Yingyong Hou, Xiaoyi Hu, et al.. (2021). No Detection of Pseudocapsule of Tumor-Parenchyma Interface on Multidetector Computed Tomography (MDCT) Images: Clinical Significance and Histological Reflections in Renal Cell Carcinoma. Cancer Management and Research. Volume 13. 5403–5411. 2 indexed citations
5.
Xi, Wei, Yingyong Hou, Xiaoyi Hu, et al.. (2021). Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Translational Andrology and Urology. 10(11). 4132–4141. 2 indexed citations
6.
Xi, Wei, et al.. (2017). [Oral health status of patients undergoing hemodialysis: a Meta-analysis].. PubMed. 35(2). 155–161. 3 indexed citations
7.
8.
Wang, Jiajun, Li Liu, Yang Qu, et al.. (2017). HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. Cancer Immunology Immunotherapy. 67(1). 79–87. 5 indexed citations
9.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2017). Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. BMC Cancer. 17(1). 117–117. 10 indexed citations
10.
Wang, Jiajun, Li Liu, Qilai Long, et al.. (2017). Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma. Oncology Letters. 14(2). 1550–1560. 7 indexed citations
11.
Yang, Fei, Yan Wang, Jian Wu, et al.. (2017). Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma. Oncology Letters. 14(3). 2757–2764. 18 indexed citations
12.
Liu, Li, Ying Xiong, Wei Xi, et al.. (2017). Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma. Oncotarget. 8(9). 14995–15003. 3 indexed citations
13.
Xia, Yu, Li Liu, Qi Bai, et al.. (2016). Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma. Scientific Reports. 6(1). 32657–32657. 16 indexed citations
14.
Xi, Wei, Li Liu, Jiajun Wang, et al.. (2016). High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma. Scientific Reports. 6(1). 29177–29177. 18 indexed citations
15.
Xu, Aiming, Yibo Hua, Jianzhong Zhang, et al.. (2016). Abnormal Hypermethylation of the VDAC2 Promoter is a Potential Cause of Idiopathic Asthenospermia in Men. Scientific Reports. 6(1). 37836–37836. 21 indexed citations
16.
Cao, Jingyi, Hainan Wang, Feifei Chen, et al.. (2016). Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma. Molecular Medicine Reports. 13(5). 4238–4244. 46 indexed citations
17.
Wang, Jiajun, Li Liu, Wei Xi, et al.. (2016). Prognostic value of UTX expression in patients with clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 34(8). 338.e19–338.e27. 13 indexed citations
18.
Xiong, Ying, Li Liu, Yu Xia, et al.. (2016). High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. Oncotarget. 7(39). 63661–63668. 15 indexed citations
19.
Bai, Qi, Li Liu, Wei Xi, et al.. (2016). Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma. Oncotarget. 9(3). 3112–3120. 7 indexed citations
20.
Fang, Jianzheng, Hainan Wang, Wei Xi, et al.. (2015). Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cells. Tumor Biology. 36(7). 5209–5214. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Mingwei Chen Breakdown of academic impact, for papers by Chao‐Tao Tang Breakdown of academic impact, for papers by Kakil Ibrahim Rasul Breakdown of academic impact, for papers by Duygu Derin Breakdown of academic impact, for papers by Andrew R. Zaretsky Breakdown of academic impact, for papers by Tzu-Chin Wu Breakdown of academic impact, for papers by Bojian Xie Breakdown of academic impact, for papers by Yihua Huang
Rankless by CCL
2026